Editas Medicine Inc (EDIT)
5.208
+0.04
(+0.73%)
USD |
NASDAQ |
May 31, 16:00
5.20
-0.01
(-0.14%)
After-Hours: 20:00
Editas Medicine 1 Year Total Returns (Daily): -43.27% for May 31, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 31, 2024 | -43.27% |
| May 30, 2024 | -42.30% |
| May 29, 2024 | -43.96% |
| May 28, 2024 | -41.54% |
| May 24, 2024 | -40.42% |
| May 23, 2024 | -39.14% |
| May 22, 2024 | -37.55% |
| May 21, 2024 | -40.88% |
| May 20, 2024 | -40.77% |
| May 17, 2024 | -41.52% |
| May 16, 2024 | -38.32% |
| May 15, 2024 | -40.06% |
| May 14, 2024 | -40.71% |
| May 13, 2024 | -40.40% |
| May 10, 2024 | -46.75% |
| May 09, 2024 | -45.89% |
| May 08, 2024 | -47.66% |
| May 07, 2024 | -41.86% |
| May 06, 2024 | -42.07% |
| May 03, 2024 | -32.18% |
| May 02, 2024 | -28.59% |
| May 01, 2024 | -34.10% |
| April 30, 2024 | -36.15% |
| April 29, 2024 | -34.19% |
| April 26, 2024 | -32.66% |
| Date | Value |
|---|---|
| April 25, 2024 | -32.21% |
| April 24, 2024 | -32.02% |
| April 23, 2024 | -33.25% |
| April 22, 2024 | -31.54% |
| April 19, 2024 | -32.14% |
| April 18, 2024 | -31.14% |
| April 17, 2024 | -31.42% |
| April 16, 2024 | -22.92% |
| April 15, 2024 | -19.89% |
| April 12, 2024 | -2.36% |
| April 11, 2024 | -1.94% |
| April 10, 2024 | 0.00% |
| April 09, 2024 | 1.30% |
| April 08, 2024 | -2.89% |
| April 05, 2024 | -1.90% |
| April 04, 2024 | -2.30% |
| April 03, 2024 | -3.11% |
| April 02, 2024 | -5.24% |
| April 01, 2024 | 0.41% |
| March 28, 2024 | 4.36% |
| March 27, 2024 | -0.13% |
| March 26, 2024 | -3.22% |
| March 25, 2024 | -1.34% |
| March 22, 2024 | 2.33% |
| March 21, 2024 | -2.73% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-79.67%
Minimum
Sep 02 2022
206.9%
Maximum
Mar 16 2021
-6.50%
Average
-17.37%
Median
May 17 2023
1 Year Total Returns (Daily) Benchmarks
| Vertex Pharmaceuticals Inc | 40.72% |
| Bristol-Myers Squibb Co | -33.50% |
| Regeneron Pharmaceuticals Inc | 33.31% |
| Cabaletta Bio Inc | 0.79% |
| Oragenics Inc | -32.21% |